A61K 2039/625
Binding through the biotin-streptavidin system or similar
Official title: {binding through the biotin-streptavidin system or similar}
A61K2039/625 (Binding through the biotin-streptavidin system or similar) appears on 63 US grants and 116 published applications in this corpus.
Search patents in A61K- Granted patents
- 63
- Published applications
- 116
- Assignees
- 70
- Inventors
- 194
- Latest grant
- 10 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 5 |
| 2003 | 4 | 6 |
| 2004 | 5 | 9 |
| 2005 | 1 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 2 |
| 2009 | 2 | 3 |
| 2010 | 0 | 6 |
| 2011 | 2 | 8 |
| 2012 | 1 | 3 |
| 2013 | 2 | 5 |
| 2014 | 3 | 7 |
| 2015 | 5 | 3 |
| 2016 | 4 | 5 |
| 2017 | 1 | 2 |
| 2018 | 1 | 2 |
| 2019 | 2 | 7 |
| 2020 | 4 | 10 |
| 2021 | 2 | 4 |
| 2022 | 2 | 2 |
| 2023 | 5 | 7 |
| 2024 | 8 | 6 |
| 2025 | 1 | 8 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Multiple antigen presenting immunogenic composition, and methods and uses thereof10 Feb 2026US 12,545,710 B2Children's Medical Center Corporation
- Scaffolds with stabilized MHC molecules for immune-cell manipulation16 Dec 2025US 12,497,592 B2Danmarks Tekniske Universitet
- Methods, kits, agents and apparatuses for transduction29 Oct 2024US 12,129,477 B2Juno Therapeutics, Inc.
- Combined vaccine against mycobacterium tuberculosis17 Sep 2024US 12,090,198 B2Children's Medical Center Corporation
- Protein antigens that provide protection against pneumococcal colonization and/or disease10 Sep 2024US 12,083,173 B2Children's Medical Center Corporation
- Modified biotin-binding protein, fusion proteins thereof and applications10 Sep 2026US 2026/0265313 A1Children's Medical Center Corporation
- Multiple antigen presenting system (maps) cross-linked using a bifunctional fusion protein and its use in vaccines protein and its use in vaccines30 Apr 2026US 2026/0115270 A1Children's Medical Center Corporation
- Scaffolds with stabilized mhc molecules for immune-cell manipulation19 Mar 2026US 2026/0078340 A1Danmarks Tekniske Universitet
- Method and means for enhancing therapeutic antibodies23 Oct 2025US 2025/0326863 A1UniversitäT Ulm
- Beads for targted signla delivery31 Jul 2025US 2025/0242045 A1Rubhu Biologics, Inc.
Most cited
By later US patents
- Dock-and-lock (DNL) vaccines for cancer therapy68US 7,901,680 B2IBC Pharmaceuticals, Inc. · 2011
- Cellular and serum protein anchors for modulating pharmacokinetics53US 5,843,440 ARedCell, Canada, Inc. · 1998
- Super-globuling for in vivo extended lifetimes50US 5,612,034 ARedCell, Inc. · 1997
- Enhancement of antigen immunogenicity46US 5,194,254 AConnaught Laboratories Limited · 1993
- Immunogenic formulations comprising oil bodies43US 6,761,914 B2SemBioSys Genetics Inc. · 2004